CEDARHURST, N.Y., March 10, 2020 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.
Portola Pharmaceuticals, Inc. (PTLA)
Investors Affected: January 8, 2019 - February 26, 2020
Lead Plaintiff Motion Deadline: March 16, 2020
SECURITIES FRAUD, MISLEADING PROSPECTUS
Shareholders may find more information at https://kclasslaw.com/cases/securities/nasdaqgs-ptla/
Qudian Inc. (QD)
Investors Affected: December 13, 2018 - January 15, 2020
Lead Plaintiff Motion Deadline: March 23, 2020
Shareholders may find more information at https://kclasslaw.com/cases/securities/nyse-qd/
Align Technology, Inc. (ALGN)
Investors Affected: April 24, 2019 – July 24, 2019
Lead Plaintiff Motion Deadline: May 1, 2020
Shareholders may find more information at https://kclasslaw.com/cases/securities/nasdaqgs-algn/
World Wrestling Entertainment, Inc. (WWE)
Investors Affected: February 7, 2019 - February 5, 2020
Lead Plaintiff Motion Deadline: May 5, 2020
Shareholders may find more information at https://kclasslaw.com/cases/securities/nyse-wwe/
Shareholders who purchased shares in these companies during the dates listed are encouraged to contact us via the case links above, by calling toll-free at 1-833-835-1495 or by email (email@example.com).
If you wish to serve as lead plaintiff with the goal of overseeing the litigation to obtain a fair and just resolution, you must petition the Court on or before the deadlines provided above.
Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967